Lu J - Search Results

1

Identification and integrated analysis of key differentially expressed circular RNAs in ER-positive subtype breast cancer.

Yuan C, Zhou L, Zhang L, Yin K, Peng J, Sha R, Zhang S, Xu Y, Sheng X, Wang Y, Lin Y, Xu S, Yin W, Lu J. Yuan C, et al. Among authors: lu j. Epigenomics. 2019 Feb;11(3):297-321. doi: 10.2217/epi-2018-0147. Epub 2018 Nov 12. Epigenomics. 2019. PMID: 30417652

2

[Expression of ER alpha in chemically induced MDA-MB-435 cells and its responsiveness to endocrine].

Fan J, Lu JS, Yin WJ, Lei W, Wu FY, Wu J, Hou YF, Li DQ, Di GH, Shen ZZ, Shao ZM. Fan J, et al. Among authors: lu js. Zhonghua Zhong Liu Za Zhi. 2006 Dec;28(12):886-9. Zhonghua Zhong Liu Za Zhi. 2006. PMID: 17533736 Chinese.

3

Identification of the functional role of AF1Q in the progression of breast cancer.

Chang XZ, Li DQ, Hou YF, Wu J, Lu JS, Di GH, Jin W, Ou ZL, Shen ZZ, Shao ZM. Chang XZ, et al. Among authors: lu js. Breast Cancer Res Treat. 2008 Sep;111(1):65-78. doi: 10.1007/s10549-007-9761-y. Epub 2007 Oct 11. Breast Cancer Res Treat. 2008. PMID: 17929166

4

[Clinico-pathological features of ER+/PR+ and ER+/PR- breast tumors: a comparative study of 5211 cases].

Zhou LH, Yin WJ, Lu JS, DI GH, Wu J, Shen KW, Han QX, Shen ZZ, Shao ZM. Zhou LH, et al. Among authors: lu js. Zhonghua Yi Xue Za Zhi. 2007 Oct 23;87(39):2764-7. Zhonghua Yi Xue Za Zhi. 2007. PMID: 18167267 Chinese.

5

ER alpha negative breast cancer cells restore response to endocrine therapy by combination treatment with both HDAC inhibitor and DNMT inhibitor.

Fan J, Yin WJ, Lu JS, Wang L, Wu J, Wu FY, Di GH, Shen ZZ, Shao ZM. Fan J, et al. Among authors: lu js. J Cancer Res Clin Oncol. 2008 Aug;134(8):883-90. doi: 10.1007/s00432-008-0354-x. Epub 2008 Feb 9. J Cancer Res Clin Oncol. 2008. PMID: 18264725

6

Time-varying pattern of recurrence risk for Chinese breast cancer patients.

Yin W, Di G, Zhou L, Lu J, Liu G, Wu J, Shen K, Han Q, Shen Z, Shao Z. Yin W, et al. Among authors: lu j. Breast Cancer Res Treat. 2009 Apr;114(3):527-35. doi: 10.1007/s10549-008-0022-5. Epub 2008 Apr 19. Breast Cancer Res Treat. 2009. PMID: 18425576

7

Clinicopathological features of the triple-negative tumors in Chinese breast cancer patients.

Yin WJ, Lu JS, Di GH, Lin YP, Zhou LH, Liu GY, Wu J, Shen KW, Han QX, Shen ZZ, Shao ZM. Yin WJ, et al. Among authors: lu js. Breast Cancer Res Treat. 2009 May;115(2):325-33. doi: 10.1007/s10549-008-0096-0. Epub 2008 Jun 18. Breast Cancer Res Treat. 2009. PMID: 18563552

8

Site-specific relapse pattern of the triple negative tumors in Chinese breast cancer patients.

Lin Y, Yin W, Yan T, Zhou L, Di G, Wu J, Shen Z, Shao Z, Lu J. Lin Y, et al. Among authors: lu j. BMC Cancer. 2009 Sep 24;9:342. doi: 10.1186/1471-2407-9-342. BMC Cancer. 2009. PMID: 19778431 Free PMC article.

9

Molecular subtype approximated by quantitative estrogen receptor, progesterone receptor and Her2 can predict the prognosis of breast cancer.

Chen XS, Ma CD, Wu JY, Yang WT, Lu HF, Wu J, Lu JS, Shao ZM, Shen ZZ, Shen KW. Chen XS, et al. Among authors: lu hf, lu js. Tumori. 2010 Jan-Feb;96(1):103-10. doi: 10.1177/030089161009600117. Tumori. 2010. PMID: 20437866

10

The prognostic role of cancer stem cells in breast cancer: a meta-analysis of published literatures.

Zhou L, Jiang Y, Yan T, Di G, Shen Z, Shao Z, Lu J. Zhou L, et al. Among authors: lu j. Breast Cancer Res Treat. 2010 Aug;122(3):795-801. doi: 10.1007/s10549-010-0999-4. Epub 2010 Jun 23. Breast Cancer Res Treat. 2010. PMID: 20571867

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34,041 results

Search Page

Filters